ASS1 and cancer: Cancer cells consume significantly more arginine compared to their normal counterparts due to robust biosynthesis and the downregulation of argininosuccinate synthetase (ASS1), a rate-limiting enzyme in arginine synthesis, in a range of hematological and solid tumors7.